Opus Genetics, Inc. Proceeds from Issuance or Sale of Equity
Opus Genetics, Inc. (IRD) reported Proceeds from Issuance or Sale of Equity of $16.68 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2018-11-02
- Opus Genetics, Inc. proceeds from issuance or sale of equity for the quarter ending 2017-12-31 was $7.44M.
- Opus Genetics, Inc. proceeds from issuance or sale of equity for the quarter ending 2017-09-30 was -$113.73K, a 102.05% decline year-over-year.
- Opus Genetics, Inc. proceeds from issuance or sale of equity for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- Opus Genetics, Inc. proceeds from issuance or sale of equity for the quarter ending 2016-09-30 was $5.54M.
- Opus Genetics, Inc. proceeds from issuance or sale of equity for fiscal 2017 was $16.68M, a 64.80% increase from fiscal 2016.
- Opus Genetics, Inc. proceeds from issuance or sale of equity for fiscal 2016 was $10.12M, a 36.05% increase from fiscal 2015.
- Opus Genetics, Inc. proceeds from issuance or sale of equity for fiscal 2015 was $7.44M, a 60.07% decline from fiscal 2014.
- Opus Genetics, Inc. proceeds from issuance or sale of equity for fiscal 2014 was $18.63M, a 85.58% increase from fiscal 2013.
| Period end | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month | Proceeds from Issuance or Sale of Equity 132 month | Proceeds from Issuance or Sale of Equity 135 month | Proceeds from Issuance or Sale of Equity 138 month | Proceeds from Issuance or Sale of Equity 141 month | Proceeds from Issuance or Sale of Equity 144 month | Proceeds from Issuance or Sale of Equity 147 month | Proceeds from Issuance or Sale of Equity 150 month | Proceeds from Issuance or Sale of Equity 153 month | Proceeds from Issuance or Sale of Equity 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $7.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $7.33M derived: sum of 2 quarters · filed 2018-11-02 | $16.68M 10-K · filed 2018-03-09 | ||||||||||
| 2017-09-30 | -$113.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $9.24M 10-Q · filed 2018-11-02 | |||||||||||
| 2017-06-30 | $9.36M 10-Q · filed 2018-08-03 | ||||||||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $5.54M derived: sum of 2 quarters · filed 2018-03-09 | $5.54M derived: sum of 3 quarters · filed 2018-03-09 | $10.12M 10-K · filed 2018-03-09 | |||||||||
| 2016-09-30 | $5.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $5.54M derived: sum of 2 quarters · filed 2017-11-03 | $10.12M 10-Q · filed 2017-11-03 | $16.56M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $4.58M 10-Q · filed 2017-08-04 | $11.01M derived: sum of 3 quarters · filed 2018-03-09 | $11.01M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||
| 2016-03-31 | $4.58M 10-Q · filed 2017-05-03 | $11.01M derived: sum of 2 quarters · filed 2018-03-09 | $11.01M derived: sum of 3 quarters · filed 2018-03-09 | ||||||||||
| 2015-12-31 | $6.43M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $6.43M derived: sum of 2 quarters · filed 2018-03-09 | $7.44M 10-K · filed 2018-03-09 | ||||||||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $1.01M 10-Q · filed 2016-11-04 | |||||||||||
| 2015-06-30 | $1.01M 10-Q · filed 2016-08-05 | ||||||||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $0.00 derived: sum of 2 quarters · filed 2017-02-24 | $0.00 derived: sum of 3 quarters · filed 2017-02-24 | $18.63M 10-K · filed 2017-02-24 | |||||||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $0.00 derived: sum of 2 quarters · filed 2015-11-02 | $18.63M 10-Q · filed 2015-11-02 | $23.50M derived: sum of 4 quarters · filed 2016-03-14 | |||||||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $18.63M 10-Q · filed 2015-08-07 | $23.50M derived: sum of 3 quarters · filed 2016-03-14 | $28.68M derived: sum of 4 quarters · filed 2016-03-14 | |||||||||
| 2014-03-31 | $18.63M 10-Q · filed 2015-05-08 | $23.50M derived: sum of 2 quarters · filed 2016-03-14 | $28.68M derived: sum of 3 quarters · filed 2016-03-14 | $28.68M derived: sum of 4 quarters · filed 2016-03-14 | $91.61M 10-Q · filed 2014-05-14 | ||||||||
| 2013-12-31 | $4.87M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $10.04M derived: sum of 2 quarters · filed 2016-03-14 | $10.04M derived: sum of 3 quarters · filed 2016-03-14 | $10.04M 10-K · filed 2016-03-14 | $72.98M 10-K · filed 2014-03-21 | ||||||||
| 2013-09-30 | $5.17M derived: 10-Q 150 month − 10-Q 147 month · filed 2013-11-13 | $5.17M derived: sum of 2 quarters · filed 2013-11-13 | $5.17M 10-Q · filed 2014-11-12 | $12.30M derived: sum of 4 quarters · filed 2013-11-13 | $68.11M 10-Q · filed 2013-11-13 | ||||||||
| 2013-06-30 | $0.00 derived: 10-Q 147 month − 10-Q 144 month · filed 2013-08-12 | $0.00 derived: sum of 2 quarters · filed 2013-08-12 | $7.13M derived: sum of 3 quarters · filed 2013-08-12 | $7.13M derived: sum of 4 quarters · filed 2013-08-12 | $62.93M 10-Q · filed 2013-08-12 | ||||||||
| 2013-03-31 | $0.00 derived: 10-Q 144 month − 10-K 141 month · filed 2013-05-09 | $7.13M derived: sum of 2 quarters · filed 2013-05-09 | $7.13M derived: sum of 3 quarters · filed 2013-05-09 | $7.13M derived: sum of 4 quarters · filed 2013-05-09 | $62.93M 10-Q · filed 2013-05-09 | ||||||||
| 2012-12-31 | $7.13M derived: 10-K 141 month − 10-Q 138 month · filed 2013-03-22 | $7.13M derived: sum of 2 quarters · filed 2013-03-22 | $7.13M derived: sum of 3 quarters · filed 2013-03-22 | $7.13M 10-K · filed 2014-03-21 | $62.93M 10-K · filed 2013-03-22 | ||||||||
| 2012-09-30 | $0.00 derived: 10-Q 138 month − 10-Q 135 month · filed 2012-11-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-08 | $0.00 derived: sum of 3 quarters · filed 2012-11-08 | $0.00 derived: sum of 4 quarters · filed 2013-03-22 | $55.81M 10-Q · filed 2012-11-08 | ||||||||
| 2012-06-30 | $0.00 derived: 10-Q 135 month − 10-Q 132 month · filed 2012-08-08 | $0.00 derived: sum of 2 quarters · filed 2012-08-08 | $0.00 derived: sum of 3 quarters · filed 2013-03-22 | $0.00 derived: sum of 4 quarters · filed 2013-03-22 | $55.81M 10-Q · filed 2012-08-08 | ||||||||
| 2012-03-31 | $0.00 10-Q · filed 2012-05-09 | $0.00 derived: sum of 2 quarters · filed 2013-03-22 | $0.00 derived: sum of 3 quarters · filed 2013-03-22 | $0.00 derived: sum of 4 quarters · filed 2013-03-22 | $55.81M 10-Q · filed 2012-05-09 | ||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | $0.00 derived: sum of 2 quarters · filed 2013-03-22 | $0.00 derived: sum of 3 quarters · filed 2013-03-22 | $13.22M 10-K · filed 2013-03-22 | |||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-08 | $13.22M 10-Q · filed 2012-11-08 | $13.22M derived: sum of 4 quarters · filed 2012-11-08 | |||||||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $13.22M 10-Q · filed 2012-08-08 | $13.22M derived: sum of 3 quarters · filed 2012-08-08 | $13.22M derived: sum of 4 quarters · filed 2012-08-08 | |||||||||
| 2011-03-31 | $13.22M 10-Q · filed 2012-05-09 | $13.22M derived: sum of 2 quarters · filed 2012-05-09 | $13.22M derived: sum of 3 quarters · filed 2012-05-09 | ||||||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | $0.00 derived: sum of 2 quarters · filed 2012-03-16 | $9.32M 10-K · filed 2012-03-16 | ||||||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $9.32M 10-Q · filed 2011-11-09 | |||||||||||
| 2010-06-30 | $9.32M 10-Q · filed 2011-08-09 | ||||||||||||
| 2009-12-31 | $10.73M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |